Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Progress in Cardiovascular Diseases|January 10, 2012
The high-risk myocardial infarction database initiativeKenneth Dickstein, Judith Bebchuk, Janet Wittes
Obstetrics and Gynecology|May 9, 2014
Repeat midurethral sling compared with urethral bulking for recurrent stress urinary incontinenceAnthony Gaddi, Noelani Guaderrama, Nora Bassiouni, et al.
Journal of Minimally Invasive Gynecology|August 5, 2015
Laparoscopic Hysterectomy and Urinary Tract Injury: Experience in a Health Maintenance OrganizationJasmine Tan-Kim, Shawn A Menefee, Caryl S Reinsch, et al.
American Journal of Medical Genetics. Part A|October 22, 2008
Safety and efficacy of 22 weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuriaPhillip Lee, Eileen P Treacy, Eric Crombez, et al.
International Journal of Cardiology|December 1, 2012
Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANTSally C Inglis, Judith Bebchuk, Sultan A Al-Suhaim, et al.
Clinical Lung Cancer|January 19, 2025
Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket TrialJonathan W Goldman, Alejandro Martinez Bueno, Christophe Dooms, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast CancerCristina Saura, Judit Matito, Mafalda Oliveira, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket TrialKomal Jhaveri, Lisa D Eli, Sara A Hurvitz, et al.
The Oncologist|May 24, 2021
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA TrialSara A Hurvitz, Cristina Saura, Mafalda Oliveira, et al.
The Journal of Pediatrics|March 6, 2009
Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled studyFriedrich K Trefz, Barbara K Burton, Nicola Longo, et al.
Pageof 2